These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19726581)

  • 1. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series.
    MacConnachie AA; Fox R; Kennedy DR; Seaton RA
    QJM; 2009 Nov; 102(11):781-4. PubMed ID: 19726581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
    Lee S; Drennan K; Simons G; Hepple A; Karlsson K; Lowman W; Gaylard PC; McNamara L; Fabian J
    S Afr Med J; 2018 Apr; 108(5):403-407. PubMed ID: 29843854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients.
    Yoon SS; Brandt LJ
    J Clin Gastroenterol; 2010 Sep; 44(8):562-6. PubMed ID: 20463588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial diarrhoea in adult medical patients: the role of Clostridium difficile in a North Italian acute care teaching hospital.
    Sansone S; Aschbacher R; Staffler M; Bombonato M; Girardi F; Larcher C; Wiedermann CJ
    J Prev Med Hyg; 2009 Jun; 50(2):117-20. PubMed ID: 20099443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease.
    Guo B; Harstall C; Louie T; Veldhuyzen van Zanten S; Dieleman LA
    Aliment Pharmacol Ther; 2012 Apr; 35(8):865-75. PubMed ID: 22360412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First recurrence of Clostridium difficile infection: clinical relevance, risk factors, and prognosis.
    Larrainzar-Coghen T; Rodriguez-Pardo D; Puig-Asensio M; Rodríguez V; Ferrer C; Bartolomé R; Pigrau C; Fernández-Hidalgo N; Pumarola T; Almirante B
    Eur J Clin Microbiol Infect Dis; 2016 Mar; 35(3):371-8. PubMed ID: 26753991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with Clostridium difficile diarrhea in a hospital in Beijing, China.
    Lv Z; Peng GL; Su JR
    Braz J Med Biol Res; 2014 Dec; 47(12):1085-90. PubMed ID: 25387676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea.
    Garborg K; Waagsbø B; Stallemo A; Matre J; Sundøy A
    Scand J Infect Dis; 2010 Dec; 42(11-12):857-61. PubMed ID: 20662620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplant by push enteroscopy to treat diarrhea caused by Clostridium difficile.
    Ganc AJ; Ganc RL; Reimão SM; Frisoli Junior A; Pasternak J
    Einstein (Sao Paulo); 2015; 13(2):338-9. PubMed ID: 26154556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile-positive stools: a retrospective identification of risk factors.
    Howitt JR; Grace JW; Schaefer MG; Dolder C; Cannella C; Schaefer RS
    Am J Infect Control; 2008 Sep; 36(7):488-91. PubMed ID: 18786452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics.
    McFarland LV; Surawicz CM; Rubin M; Fekety R; Elmer GW; Greenberg RN
    Infect Control Hosp Epidemiol; 1999 Jan; 20(1):43-50. PubMed ID: 9927265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of Clostridium difficile-associated diarrhoea in a community hospital.
    Tomkins K; Raynor J; Rothwell L; DeSilva J; Wilson C
    West Indian Med J; 2011 Jan; 60(1):57-60. PubMed ID: 21809713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nosocomial Clostridium difficile-associated diarrhoea in Assiut University Children's Hospital, Egypt.
    Abu Faddan NH; Aly SA; Abou Faddan HH
    Paediatr Int Child Health; 2016 Feb; 36(1):39-44. PubMed ID: 25496416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?
    Cunningham R; Dial S
    J Hosp Infect; 2008 Sep; 70(1):1-6. PubMed ID: 18602190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinical features of Clostridium difficile-associated diarrhea in a tertiary hospital in northern Taiwan.
    Hsu MS; Wang JT; Huang WK; Liu YC; Chang SC
    J Microbiol Immunol Infect; 2006 Jun; 39(3):242-8. PubMed ID: 16783456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.
    Kelly CR; de Leon L; Jasutkar N
    J Clin Gastroenterol; 2012 Feb; 46(2):145-9. PubMed ID: 22157239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection.
    Kassam Z; Hundal R; Marshall JK; Lee CH
    Arch Intern Med; 2012 Jan; 172(2):191-3. PubMed ID: 22271132
    [No Abstract]   [Full Text] [Related]  

  • 19. [Feces culture successful therapy in Clostridium difficile diarrhea].
    Jorup-Rönström C; Håkanson A; Persson AK; Midtvedt T; Norin E
    Lakartidningen; 2006 Nov 15-21; 103(46):3603-5. PubMed ID: 17153868
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea.
    Shim JK; Johnson S; Samore MH; Bliss DZ; Gerding DN
    Lancet; 1998 Feb; 351(9103):633-6. PubMed ID: 9500319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.